Quantitative and qualitative profiling of endocannabinoids in human plasma using a triple quadrupole linear ion trap mass spectrometer with liquid chromatography

Rapid Communications in Mass Spectrometry

Volumn 23, Issue 5, 2009, Pages 629-638

  Thomas, Aurélien ^a   Hopfgartner, Gérard ^b   Giroud, Christian ^a   Staub, Christian ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONS; MASS SPECTROMETERS; PLASMA (HUMAN);

2-ARACHIDONOYL GLYCEROLS; CONCENTRATION RANGES; DOPAMINE; ENDOCANNABINOID; HUMAN PLASMAS; ION TRAP MASS SPECTROMETER; LINEAR ION TRAP; LIQUID CHROMATOGRAPHY ELECTROSPRAY; PATHOPHYSIOLOGICAL; TRIPLE QUADRUPOLE;

MASS SPECTROMETRY;

EID: 62549147814     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3918     Document Type: Article

References (40)

1. De Petrocellis L, Cascio MG, Di Marzo V. Br. J. Pharmacol. 2004; 141: 765.
2. Piomelli D. Nat. Rev. Neurosci. 2003; 4: 873.
3. Mangieri RA, Piomelli D. Pharmacol. Res. 2007; 56: 360.
4. Viveros MP, Marco EM, File SE. Pharmacol. Biochem. Behav. 2005; 81: 331.
5. Monteleone P, Matias I, Martiadis V, De Petrocellis L, Maj M, Di Marzo V. Neuropsychopharmacology 2005; 30: 1216.
6. Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L, et al. Schizophr Res. 2007; 94: 29.
7. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, et al. Gastroenterology 2003; 125: 677.
8. Maldonado R, Valverde O, Berrendero F. Trends Neurosci. 2006; 29: 225.
9. Di Marzo V, Petrosino S. Curr. Opin. Lipidol. 2007; 18: 129.
10. Gomez-Ruiz M, Hernandez M, de Miguel R, Ramos JA. Mol. Neurobiol. 2007; 36: 3.
11. Fowler CJ, Jacobsson SO. Prostaglandins Leukot. Essent. Fatty Acids 2002; 66: 193.
12. Kozak KR, Marnett LJ. Prostaglandins Leukot. Essent. Fatty Acids 2002; 66: 211.
13. Sugiura T, Kobayashi Y, Oka S, Waku K. Leukot. Essent. Fatty Acids 2002; 66: 173.
14. Guiffreda A, Piomelli D. In Lipid Second Messengers, Lychock SG, Rubin RP (eds). CRC Press: Boca Raton; London, New York, Washington, 1998; 113-133.
15. Kingsley PJ, Marnett LJ. Methods Enzymol. 2007; 433: 91.
16. Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamakuchi M, et al. Anal. Biochem. 2001; 294: 73.
17. De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. Lipids Health Dis. 2003; 2: 5.
18. Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H, Waku K, Sugiura T. J. Neurochem. 2003; 85: 1374.
19. Fezza F, Bisogno T, Minassi A, Appendino G, Mechoulam R, Di Marzo V. FEBS Lett. 2002; 513: 294.
20. Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA. Anal. Biochem. 2007; 360: 216.
21. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC. J. Pharmacol. Exp. Ther. 2002; 301: 1020.
22. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V. Proc. Natl. Acad. Sci. 2002; 99: 8400.
23. Bradshaw HB, Rimmerman N, Krey JF, Walker JM. Am. J. Physiol. Integr. Comp. Physiol. 2006; 291: R349.
24. Tan B, Bradshaw HB, Rimmerman N, Srinivasan H, Yu YW, Krey JF, Monn MF, Chen JSC, Hu SSJ, Pickens SR, Walker JM. Am. Assn. Pharmaceutical Scientists 2006; 8: E461.
25. Boulanger B, Chiap P, Dewé W, Crommen J, Hubert P. J. Pharm. Biomed. Anal. 2003; 32: 753.
26. Hubert P, Chiap P, Crommen J, Boulanger B, Chapuzet E, Mercier N, Bervoas-Martin S, Chevalier P, Grandjean D, Lagorce P, Lallier M, Laparra MC, Laurentie M, Nivet JC. Anal. Chim. Acta 1999; 391: 135.
27. Rouzer CA, Ghebreselasie K, Marnett LJ. Chem. Phys. Lipids 2002; 119: 69.
28. Kingsley PJ, Marnett LJ. Anal. Biochem. 2003; 314: 8.
29. Schreiber D, Harlfinger S, Nolden BM, Gerth CW, Jaehde U, Schomig E, Klosterkotter J, Guiffreda A, Astarita G, Piomel D, Leweke FM. Anal. Biochem. 2007; 361: 162.
30. Hopfgartner G, Varesio E, Tschappat V, Grivet C, Bourgogne E, Leuthold LA. J. Mass Spectrom. 2004; 39: 845.
31. Cheng C, Gross ML. Mass Spectrom. Rev. 2000; 19: 398.
32. Wysocki VH, Ross MM. Int. J. Mass Spectrom. Ion Processes 1991; 104: 179.
33. Thomas A, Widmer C, Hopfgartner G, Staub C. J. Pharm. Biomed. Anal. 2007; 45: 495.
34. Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Cohen N, Compagnon NA, Dewé W, Feinberg M, Laurentie M, Mercier N, Muzard G, Valat L. S. T. P. Pharma. Pratiques 2006; 16: 28.
35. Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N, Compagnon NA, Dewé W, Feinberg M, lallier M, Laurentie M, Mercier N, Muzard G, Nivet C, Valat L. J. Pharm. Biomed. Anal. 2004; 36: 579.
36. Hoffman D, Kringle R. Pharm. Res. 2007; 24: 1157.
37. Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Cohen N, Compagnon NA, Dewé W, Feinberg M, Laurentie M, Mercier N, Muzard G, Valat L, Rozet E. J. Pharm. Biomed. Anal. 2007; 45: 82.
38. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Anal. Chem. 2003; 75: 3019.
39. Souverain S, Rudaz S, Veuthey JL. J. Chromatogr. A 2004; 158: 61.
40. Timm U, Wall M, Dell D. J. Pharm. Sci. 1985; 74: 972.